ATGL was reported to be downregulated or lost in several human malignant tumors and low levels of ATGL correlate with significantly reduced survival rate in patients with ovarian, breast, gastric, and non‐small cell lung cancers [62]. This evidence concerns the gene PNPLA2 and lung cancer.